Glycoconjugates As Vaccines for Cancer Immunotherapy: Clinical Trials and Future Directions

E-ISSN： 1875-5992|8|1|86-91

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.8, Iss.1, 2008-01, pp. : 86-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical trials of immunotherapy for advanced prostate cancer

By Kuratsukuri K. Nishisaka N. Jones R.F. Wang C.Y. Haas G.P.

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 6, 2000-11 ,pp. : 265-273

Elsevier

Access to resources Recommend Favorite

Systemic Immunotherapy for Urothelial Cancer: Current Trends and Future Directions

By Gupta Shilpa Gill David Poole Austin Agarwal Neeraj

Cancers, Vol. 9, Iss. 2, 2017-01 ,pp. : 15-15

MDPI

Access to resources Recommend Favorite

Panitumumab: a summary of clinical development in colorectal cancer and future directions

By Argiles Guillem Dienstmann Rodrigo Elez Elena Tabernero Josep

Future Oncology, Vol. 8, Iss. 4, 2012-04 ,pp. : 373-389

Future Medicine

Access to resources Recommend Favorite

Carcinoembryonic Antigen (CEA)-Based Cancer Vaccines: Recent Patents and Antitumor Effects from Experimental Models to Clinical Trials

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 3, 2012-09 ,pp. : 265-296

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Immunotherapy Trials Underutilize Immune Response Monitoring

The Oncologist, Vol. 23, Iss. 1, 2018-01 ,pp. : 116-117

John Wiley & Sons Inc

Access to resources Recommend Favorite